Viewing Study NCT07238569


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-25 @ 8:20 PM
Study NCT ID: NCT07238569
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module